Columbia, MD, United States of America

Benjamin Wolozin

This inventor holds 1 USPTO granted patent. Top assignee: Albert Einstein College of Medicine. Active years: 1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Benjamin Wolozin. Retrieved from https://idiyas.com/inventor/benjamin-wolozin-2ckeem7l

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 23(Granted Patents)


Company Filing History:


Years Active: 1998

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Benjamin Wolozin

Introduction

Benjamin Wolozin is a notable inventor based in Columbia, MD (US). He has made significant contributions to the field of Alzheimer's research. His work focuses on developing diagnostic tools that can aid in the early detection of Alzheimer's disease.

Latest Patents

Wolozin holds a patent for "The Alz-50 monoclonal antibody and diagnostic assay for Alzheimer's." This invention relates to an antigen associated with Alzheimer's disease and to antibodies specific for said antigen. It further includes methods for diagnosing Alzheimer's disease utilizing assays containing Alzheimer's associated antigen, antibodies specific for said antigen, and samples from individuals suspected of having Alzheimer's disease. He has 1 patent to his name.

Career Highlights

Wolozin is affiliated with the Albert Einstein College of Medicine, where he conducts research and contributes to advancements in medical science. His work has been instrumental in understanding the mechanisms of Alzheimer's disease and developing potential diagnostic methods.

Collaborations

Some of his notable coworkers include Hossein A Ghanbari and Peter Davies. Their collaborative efforts have furthered research in the field of neurodegenerative diseases.

Conclusion

Benjamin Wolozin's innovative work in Alzheimer's research exemplifies the importance of scientific inquiry in addressing complex health issues. His contributions continue to pave the way for advancements in diagnostic methods for Alzheimer's disease.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…